Atherogenic risk pattern among Nigerian hypertensive and diabetic patients undergoing follow-up visit in a tertiary hospital
Keywords:
Atherogenic, indices, hypertension, diabetesAbstract
Objectives: Cardiovascular risk can be predicted using lipid ratios such as the atherogenic index which is defined as the base 10 logarithm of the ratio of plasma triglyceride (TG) to high density lipoprotein cholesterol (HDL-C) – it is a useful prognostic parameter for guiding timely interventions and has also been employed as a predictor of cardiovascular risk. However, this is rarely used in the clinical practice in developing countries including Nigeria.
Methods: This study was a hospital-based cross-sectional study of 382 hypertensive and diabetic patients attending outpatient clinics of a tertiary hospital in Nigeria. Atherogenic risk profile, was categorized as low risk (<0.1), intermediate risk (0.1–0.24), and high risk (>0.24). Predictors were established using regression analysis. Level of significance was set at p-value of <0.05 and 95% confidence interval.
Results: The mean age of participants was 56±12 years, 31.4% of participants had high atherogenic risk. This was higher among female patients (60.0%). Participants with high TC, high LDL, uncontrolled blood pressure had odds of 1.64, 1.43 and 1.17 times of developing high atherogenic risk respectively.
Conclusion: A significant proportion of participants in this study population were at risk of developing atherosclerosis. Key identified populations at risk of CVD should be considered for routine artherogenic assessment.
References
Parinita K. Study of serum lipid profile in
individuals residing in and around Nalgonda. Int J pharm Bio Sci. 2012; 2:110-116
Holmes DT, Frohlich J, Buhr KA. The concept of precision extended to the atherogenic index of plasma. ClinBiochem. 2008;41(7-8):631-5.
Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). ClinBiochem 2001; 34: 583–8.
Clara W, Gershim A, Ivan K, Laban W, Steven J. R, Rebecca N. N et al. Atherogenic Risk Assessment among Persons Living in Rural Uganda Hindawi Publishing Corporation Journal of Tropical Medicine Volume 2016, Article ID
0 7 3 8 9 4 , 8 p a g e s
http://dx.doi.org/10.1155/2016/7073894
Dobiásová M, Frohlich J, Sedová M, Cheung MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography.J Lipid Res. 201; 52(3):566-71.
Dobiásová M. AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice.VnitrLek.2006; 52(1):64-71
Grover SA, Levington C, Paquet S. Identifying adults who are at a low risk for significant hyperlipidemia: a validated clinical index. J ClinEpidemiol 1999; 52: 49–55.
J. J. Dalal, T. N. Padmanabhan, P. Jain, S. Patil, H. Vasnawala, and A.Gulati, “Lipitension: Interplay between dyslipidemia and hypertension,” Indian Journal of Endocrinology andMetabolism, vol. 16, no. 2, pp. 240–245, 2012.
W. B.Kannel, “Fifty years of Framingham study contributions to understanding hypertension,” Journal of Human Hypertension, vol. 14, no. 2, pp. 83–90, 2000.
A. Bottger, H. A. Van Lith, V. Kren et al., “Quantitative trait loci influencing cholesterol and phospholipid phenotypes map to
chromosomes that contain genes regulating blood pressure in the spontaneously hypertensive rat,” Journal of Clinical Investigation, vol. 98, no. 3, pp. 856–862, 1996.
F. Thomas, K. Bean, L. Guize, S. Quentzel, P. Argyriadis, and A. Benetos, “Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (< years) men and women,” European Heart Journal, vol. 23, no. 7, pp. 528–535, 2002.
P.Castelli andK. Anderson, “Apopulation at risk: prevalence of high cholesterol levels in hypertensive patients in the Framinghamstudy,” The American Journal ofMedicine, vol. 80, no. 2, pp. 33–39, 1986.
P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, pp.1837–1847, 1998.
J. Mill'an, X. Pint'o, A. Mu˜noz et al., “Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention,” Vascular Health and Risk
Management, vol. 5, pp. 757–765, 2009.
H. R. Superko and S. King, “Lipid management to reduce cardiovascular risk: a new strategy is required,” Circulation, vol. 117, pp. 560–568, 2008.
M. Dobi'a¡sov'a, “Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications,” Clinical Chemistry, vol. 50, no. 7, pp. 1113–1115, 2004.
V. Bittner, B. D. Johnson, I. Zineh et al., “The triglyceride/highdensity lipoprotein cholesterol ratio predicts all-causemortality in women with suspected myocardial ischemia. A Report From the Women's Ischemia Syndrome Evaluation (WISE),” American Heart Journal, vol. 157, no. 3, pp. 548–555, 2009.
J. M. Gaziano, C. H. Hennekens, C. J. O'Donnell, J. L. Breslow, and J. E. Buring, “Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction,” Circulation, vol. 96, no. 8, pp. 2520–2525, 1997.
U. Nwagha, E. J. Ikekpeazu, F. E. Ejezie, E. E. Neboh, and I. C. Maduka, “Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu,
Nigeria,” African Health Sciences, vol. 10, no. 3, pp. 248–252, 2010.
K. Wan, J. Zhao, H. Huang et al., “The association between triglyceride/high-density lipoprotein cholesterol ratio and all cause mortality in acute coronary syndrome after coronary
revascularization,” PLoS ONE, vol. 10,no. 4, Article IDe0123521, 2015.
W. P. Castelli, “Epidemiology of coronary heart disease: The Framingham Study,” The American Journal of Medicine, vol. 76, no. 2, pp. 4–12, 1984.
M. Dobi'a¡sov'a, “AIP—atherogenic index of plasma as a significant predictor of cardiovascular risk: fromresearch to practice,” Vnitrni Lekarstvi, vol. 52, no. 1, pp. 64–71, 2006.
G. Asiki, G. A. V. Murphy, K. Baisley et al., “Prevalence of dyslipidaemia and associated risk factors in a rural population in SouthWesternUganda: a community based survey,” PLoSONE, vol. 10, no. 5, Article ID e0126166, 2015.
G. F. Watts, “Treating patients with low HDLcholesterol: choices, issues and opportunities,” Current Controlled Trials inCardiovascular Medicine, vol. 2, no. 3, pp. 118–122, 2001.
J.Riha, A. Karabarinde, G. Ssenyomo et al., “Urbanicity andlifestyle risk factors for cardiometabolic diseases in rural Uganda: a crosssectional study,” PLoS Medicine, vol. 11, no. 7, Article ID e1001683, 2014.
J. Idemudia, E. Ugwuja, O. Afonja, E. Idogun, and N. Ugwu, “CReactive proteins and cardiovascular risk indices in hypertensivNigerians,” The Internet Journal of Cardiovascular Research, vol.
, no. 2, 2008
S. Niroumand, M. Khajedaluee, M. KhademRezaiyan et al., Atherogenic Index of Plasma (AIP): a marker of cardiovascular disease, “Medical Journal of The Islamic Republic of Iran (MJIRI), vol. 29, p. 240, 2015.
S. Yusuf, S. Hawken, S. ˆ Ounpuu et al., “Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study,” The Lancet, vol. 364, no. 9438, pp. 937–952, 2004.
P. L. Da Luz, D. Favarato, J. R. Faria-Neto Jr., P. Lemos, and A. C. P. Chagas, “High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease,” Clinics, vol. 63, no. 4, pp. 427–432, 2008.
C. J. O'Donnell and R. Elosua, “Cardiovascular risk factors. Insights from framingham heart study,” Revista Espa˜nola de Cardiolog´ýa, vol. 61, no. 3, pp. 299–310, 2008.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Research Journal of Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.
